Xofluza
| Chemical Name | baloxavir marboxil |
| Dosage Form | Tablet (oral; 20 mg, 40 mg) |
| Drug Class | Antivirals |
| System | Respiratory |
| Company | Genentech Inc. |
| Approval Year | 2018 |
Indication
- To treat acute uncomplicated influenza in healthy patients or patients who are at risk for influenza-related complications ≥ 12 years of age who have been presenting symptoms for ≤ 48 hours.